Wilkins Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4M Sell
67,094
-31,856
-32% -$7.42M 2.35% 16
2025
Q4
$20.5M Sell
98,950
-13,983
-12% -$2.77M 2.99% 7
2025
Q3
$20.9M Sell
112,933
-8,557
-7% -$1.47M 2.97% 10
2025
Q2
$18.6M Sell
121,490
-5,573
-4% -$857K 2.63% 11
2025
Q1
$21.1M Buy
127,063
+1,183
+0.9% +$185K 3.02% 10
2024
Q4
$18.2M Sell
125,880
-2,749
-2% -$426K 2.63% 10
2024
Q3
$20.8M Buy
128,629
+787
+0.6% +$125K 2.88% 9
2024
Q2
$18.7M Buy
127,842
+6,768
+6% +$1.01M 2.79% 9
2024
Q1
$19.2M Buy
121,074
+39,203
+48% +$6.24M 2.8% 9
2023
Q4
$12.8M Buy
81,871
+5,595
+7% +$858K 3.13% 9
2023
Q3
$11.9M Buy
76,276
+800
+1% +$132K 3.21% 10
2023
Q2
$12.5M Buy
75,476
+202
+0.3% +$32.6K 3.26% 7
2023
Q1
$11.7M Buy
75,274
+112
+0.1% +$18.1K 3.07% 9
2022
Q4
$13.3M Sell
75,162
-50
-0.1% -$8.63K 3.49% 6
2022
Q3
$12.3M Hold
75,212
3.6% 6
2022
Q2
$13.4M Sell
75,212
-572
-0.8% -$102K 3.54% 4
2022
Q1
$13.4M Sell
75,784
-645
-0.8% -$110K 3.03% 8
2021
Q4
$13.1M Buy
76,429
+160
+0.2% +$26.2K 2.89% 9
2021
Q3
$12.3M Sell
76,269
-122
-0.2% -$20.8K 3.01% 7
2021
Q2
$12.6M Buy
76,391
+2,455
+3% +$406K 3.1% 8
2021
Q1
$12.2M Sell
73,936
-940
-1% -$152K 3.15% 8
2020
Q4
$11.8M Sell
74,876
-1,758
-2% -$259K 3.26% 7
2020
Q3
$11.4M Buy
76,634
+325
+0.4% +$48.1K 3.4% 6
2020
Q2
$10.7M Sell
76,309
-350
-0.5% -$51K 3.4% 6
2020
Q1
$10.1M Sell
76,659
-2,325
-3% -$330K 3.67% 5
2019
Q4
$11.5M Buy
78,984
+1,935
+3% +$262K 3.27% 9
2019
Q3
$9.97M Buy
77,049
+950
+1% +$125K 3% 11
2019
Q2
$10.6M Sell
76,099
-30
-0% -$4.15K 3.18% 9
2019
Q1
$10.6M Sell
76,129
-750
-1% -$100K 3.21% 9
2018
Q4
$9.92M Sell
76,879
-250
-0.3% -$34.9K 3.29% 8
2018
Q3
$10.7M Sell
77,129
-550
-0.7% -$73.1K 3.19% 11
2018
Q2
$9.43M Sell
77,679
-975
-1% -$122K 2.97% 11
2018
Q1
$10.1M Sell
78,654
-400
-0.5% -$54.1K 3.19% 8
2017
Q4
$11M Sell
79,054
-2,797
-3% -$390K 3.3% 9
2017
Q3
$10.6M Sell
81,851
-500
-0.6% -$66.3K 3.24% 9
2017
Q2
$10.9M Sell
82,351
-858
-1% -$109K 3.46% 5
2017
Q1
$10.4M Sell
83,209
-100
-0.1% -$11.9K 3.32% 9
2016
Q4
$9.6M Buy
83,309
+3,850
+5% +$445K 3.06% 10
2016
Q3
$9.39M Sell
79,459
-1,071
-1% -$130K 3.15% 8
2016
Q2
$9.77M Sell
80,530
-950
-1% -$108K 3.31% 6
2016
Q1
$8.82M Buy
81,480
+1,700
+2% +$176K 3.23% 7
2015
Q4
$8.2M Sell
79,780
-2,322
-3% -$234K 3.08% 9
2015
Q3
$7.66M Buy
82,102
+3
+0% +$290 2.93% 10
2015
Q2
$8M Sell
82,099
-650
-0.8% -$65.1K 2.92% 10
2015
Q1
$8.32M Sell
82,749
-50
-0.1% -$5.08K 2.94% 8
2014
Q4
$8.66M Sell
82,799
-200
-0.2% -$21.1K 3.01% 8
2014
Q3
$8.85M Sell
82,999
-300
-0.4% -$31.1K 3.16% 5
2014
Q2
$8.71M Sell
83,299
-1,250
-1% -$126K 3.07% 8
2014
Q1
$8.3M Buy
84,549
+14,300
+20% +$1.33M 3.06% 7
2013
Q4
$6.43M Sell
70,249
-815
-1% -$75.1K 2.67% 16
2013
Q3
$6.16M Sell
71,064
-3,525
-5% -$316K 2.81% 15
2013
Q2
$6.4M Buy
+74,589
New +$6.33M 2.97% 13

Other funds holding JNJ

Wilkins Investment Counsel's JNJ Position: Q1 2026 in Review

Wilkins Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 32% in Q1 2026, selling an estimated $7.42M and leaving 67,094 shares worth $16.4M. The position accounts for 2.35% of the portfolio, ranked #16.

Wilkins Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.1M in Q1 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Wilkins Investment Counsel held 67,094 shares of Johnson & Johnson worth $16.4M as of Q1 2026.
  • Wilkins Investment Counsel sold 31,856 Johnson & Johnson shares in Q1 2026, an estimated $7.42M.
  • Johnson & Johnson made up 2.35% of Wilkins Investment Counsel's portfolio in Q1 2026, its #16 holding.
  • Wilkins Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Wilkins Investment Counsel's Johnson & Johnson position peaked at $21.1M in Q1 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.